Santilli, G., Schwab, R., Watson, R., Ebert, C., Aronow, B.J. and Sala, A. “Temperature-dependent modification and activation of B-MYB: Implications for cell survival” J. Biol. Chem. 280, (2005), 15628-15634.
Garcia, P., Berlanga, O., Watson, R. and Frampton, J. “Generation of a conditional allele of the B-myb gene” Genesis 43, (2005), 189-195.
Soeiro, .I, Mohamedali, A., Romanska, H.M., Lea, N.C., Child, E.S., Glassford, J., Orr, S.J., Roberts, C., Naresh, K., Lalani, E.-N., Mann, D.J., Watson, R.J., Thomas, N.S.B. and Lam, E.W.-F. “p27Kip1 and p130 cooperate to regulate haematopoietic cell proliferation in vivo” Mol. Cell. Biol. 26, (2006), 6170-6184.
Tavner, F., Frampton, J. and Watson, R. “Targeting an E2F site in the mouse genome prevents promoter silencing in quiescent and post-mitotic cells” Oncogene 26, (2007), 2727-2735.
Jammeh, S., Tavner, F., Watson, R., Thomas, H.C. and Karayiannis, P. “Effect of basal core promoter and pre-core mutations on hepatitis B virus replication” J. Gen. Virol. 89, (2008), 901-909.
Knight, A.S., Notaridou, M. and Watson, R.J. “A Lin-9 complex is recruited by B-Myb to activate transcription of G2/M genes in undifferentiated embryonal carcinoma cells” Oncogene 28, (2009), 1737-1747.
Nor Rashid, N., Yusof, R. and Watson, R.J. “Disruption of repressive p130-DREAM complexes by HPV16 E6/E7 oncoproteins is required for cell cycle progression in cervical cancer cells” J. Gen. Virol. 92, (2011), 2620–2627.
Down, C., Millour, J., Lam, E.W.-F. and Watson R.J. “Binding of FoxM1 to G2/M promoters is dependent on B-Myb” Biochim. Biophys. Acta 1819, (2012), 855-862.